Moderna falls as waning demand for COVID-19 vaccines hit sales, profit

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/21/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. TSLA
6. META
7. RTX
8. SMCI
9. GOOGL
10. S

Go back to Moderna falls as waning demand for COVID-19 vaccines hit sales, profit

Moderna (MRNA) changes point to an 'extended period of underperformance' - SVB Securities

February 24, 2023 10:16 AM EST

Moderna (NASDAQ: MRNA) was cut to Underperform from Market Perform by SVB Securities analyst Mani Foroohar on Friday.

Foroohar also lowered the firm's price target on the stock to $93 from $111 following Thursday's reported FY22 results and updated 2023 guidance which "gave a deeper... More

Moderna (MRNA) PT Lowered to $185 at Morgan Stanley Following EPS

February 23, 2023 12:39 PM EST

Morgan Stanley analyst Matthew Harrison lowered the price target on Moderna (NASDAQ: MRNA) to $185.00 (from $205.00) while maintaining a Overweight rating following earnings.

The analyst commented, "4Q22 was generally in-line. 2023 COGS of 35-40% was above expectations and the most notable downside driver in our... More